Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Semin Oncol. 2012 Feb;39(1):67–73. doi: 10.1053/j.seminoncol.2011.11.004

Table 2.

Gene mutational status in CMML patients (cohort with >50 patients).

Number (n)
of patients		 Mutated genes
 References
CBL RAS RUNX1 JAK2
(V617F) 		TET2 ASXL1 UTX EZH2 IDH1/2
63 14% 11% - 2% 48% 27% 9% 6% 5% (7)
81 19% 27% 9% 10% 51% - - - - (21)
53 10% 13% 21% - 36% 49% - - 10% (25)
88 - - - - 50% - - - - (44)
69 - - - - 42% - - - - (41)
81 - - 37% - - - - - - (27)
78 - - - 10% - - - - - (30)
52 - - - 13% - - - - - (31)